Evidence map›Paper›PMID 29791797›Full record

ArticleMolecular pharmaceutics2018

Modulating Macrophage Polarization through CCR2 Inhibition and Multivalent Engagement.

Michael B Deci, Scott W Ferguson, Sydney L Scatigno, Juliane Nguyen

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  6. Pharmacological antagonism of Ccr2+ cell recruitment to facilitate regenerative tendon healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. AMolecules (Basel, Switzerland) · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael B DeciDepartment of Pharmaceutical Sciences, School of Pharmacy , University at Buffalo, The State University of New York , Buffalo , NY 14214 , United States.
Scott W FergusonDepartment of Pharmaceutical Sciences, School of Pharmacy , University at Buffalo, The State University of New York , Buffalo , NY 14214 , United States.
Sydney L ScatignoDepartment of Pharmaceutical Sciences, School of Pharmacy , University at Buffalo, The State University of New York , Buffalo , NY 14214 , United States.
Juliane NguyenDepartment of Pharmaceutical Sciences, School of Pharmacy , University at Buffalo, The State University of New York , Buffalo , NY 14214 , United States.ORCID 0000-0002-8578-7396
University at Buffalo, State University of New York · US

Funding

RNA EXO-Codes: A novel way to reprogram pathological exosomesR01EB023262 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NGUYEN, JULIANE · 2017 to 2020
$1.7M
Self-replicating RNA-nanoplexes for programming monocytes to regenerate the heartR21HL126082 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI NGUYEN, JULIANE · 2015 to 2016
$432k
Maximizing small RNA delivery with signaling pepitdesR21EB021454 · NIBIB · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI NGUYEN, JULIANE · 2015 to 2016
$432k
NHLBI NIH HHS R21 HL126082NIBIB NIH HHS R01 EB023262NIBIB NIH HHS R21 EB021454
6 · The paper itself

Abstract

Excessive or prolonged recruitment of inflammatory monocytes to damaged tissue can significantly worsen patient outcomes. Monocytes migrate to sites of tissue inflammation in response to high local concentrations of CCL2, a chemokine that binds to and signals through the CCR2 receptor. While the role of CCR2 in cellular migration is well studied, it is unclear how CCR2 inhibition affects macrophage polarization and if multivalency can increase downstream signaling effects. Using affinity selection with a phage library, we identified a novel single-chain variable fragment (scFv) (58C) that binds specifically and with high affinity to the N-terminal domain of CCR2 ( K

Indexed as

AnimalsCell LineCell MovementHumansInflammationLeukocytes, MononuclearMacrophage ActivationMacrophagesMiceReceptors, CCR2Signal TransductionSingle-Chain AntibodiesCCR2 protein, humanReceptors, CCR2Single-Chain Antibodiescellular migrationchemokine receptorsmultivalencyphenotype switchingscFv

Identifiers

PMID29791797
PMCPMC6499372
OpenAlexW2803795060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.